Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck (Q43764068)
scientific article
Language:
(P31) (Q13442814)
(P304) 2015-2022
(P407) (Q1860)
(P433) 16
(P478) 37
(P577) Thursday, November 1, 2001
(P921) (Q18936)
(P1433) (Q332260)
(P1476) "Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck" (language: en)
(P2093) Harrington KJ
Lewanski C
Northcote AD
Whittaker J
Peters AM
Vile RG
Stewart JS
(P2860) (Q40919694)
(Q73370356)
(Q41939496)
(Q70657702)
(Q33446391)
(Q33479695)
(Q56386325)
(Q71566289)
(Q36742644)
(Q68100939)
(Q72841509)
(Q36848778)
(Q74059857)
(Q33332446)
(Q77306436)
(Q34511480)
(Q69940375)
(Q56532851)
(Q34745283)
(Q34749386)
(Q73153274)
(Q36621814)
other details
description scientific article

External Links